Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Gross Margin (2024 - 2025)

Historic Gross Margin for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to 50.63%.

  • Kestra Medical Technologies' Gross Margin rose 109900.0% to 50.63% in Q4 2025 from the same period last year, while for Oct 2025 it was 46.4%, marking a year-over-year increase of 195400.0%. This contributed to the annual value of 40.47% for FY2025, which is 391700.0% up from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' Gross Margin is 50.63%, which was up 109900.0% from 45.69% recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Gross Margin high stood at 50.63% for Q4 2025, and its period low was 10.63% during Q1 2024.